ArticleCureus2025
Keratoacanthoma in a Patient With Skin of Color.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Keratoacanthomas are rapidly growing, benign cutaneous neoplasms that can mimic squamous cell carcinoma, presenting diagnostic and management challenges for physicians. The case report investigates a 63-year-old African American female who presented to a family medicine clinic with a one-year history of a progressively enlarging nodule on her right shin. Clinical examination revealed a seven-millimeter dome-shaped, hyperpigmented, well-defined, scaly, rough papule with central umbilication and a keratin plug. Histopathological analysis of an excisional biopsy confirmed the diagnosis of keratoacanthoma with clear margins. Due to the significant overlay in gross appearance and dermoscopic features of keratoacanthomas and malignant squamous cell carcinomas, it is imperative to fully excise similarly presenting lesions and send them for microscopic analysis. Even with histologic examination, keratoacanthomas and squamous cell carcinomas can be challenging to differentiate. Therefore, the priority of contemporary research lies in new methods of distinguishing the two conditions so that the self-limited, benign keratoacanthoma can be managed more conservatively, avoiding invasive removal and associated morbidity. This scholarship is especially pertinent to patients, like the one in this case study, with skin of color who are more likely to experience post-operative complications such as proinflammatory hyperpigmentation, hypertrophic scars, and keloids, but are also at risk of squamous cell carcinoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.